• Wednesday
  • October 22, 2014
  • Last updated: 9:08pm
Hong Kong

Humidity 

UV 

Pollution 

Refine Your Search

Sort by

Search Results

Results 1 - 10 of 1001 for baoshantang pharmaceutical company

Related topics matching your search

Search results

  1. Shanghai drug firm planning US$500m IPO

    Posted Jul 15th 2004, 12:00am by Staff Reporter

    ... Andrew K. Collier in Beijing Morgan Stanley is expected to manage the listing that will fund expansion Shanghai Pharmaceutical, China's largest drug company, is seeking to raise ... Established in 1926, Shanghai Pharmaceutical had sales last year of almost US$3 billion in a $17 billion industry that is forecast to grow to $60 billion by 2010. The company has a strong position ...

    http://www.scmp.com/article/463175/shanghai-drug-firm-planning-us500m-ipo
  2. EcoGreen targets $147m for growth

    Posted Feb 21st 2004, 12:00am by Eric Ng

    ... proceeds to develop overseas markets and commercialise pharmaceutical intermediaries under development. The company had a net profit of about 33 million yuan in 2002, on turnover of about 150 ... to expand production capacity and develop new products, according to market sources. The privately owned company, based in Xiamen, Fujian province, plans to sell 100 million H shares at between ...

    http://www.scmp.com/article/445371/ecogreen-targets-147m-growth
  3. Broad Intelligence seeks to raise $78m

    Posted Nov 11th 2003, 12:00am by Toh Han Shih

    ... Toh Han Shih Mainland drug firm Broad Intelligence International Pharmaceutical Holdings is seeking to raise about $78 million from a listing on the main board. The company's 97.2 ... are listing in Hong Kong to raise our international profile. We are expanding internationally. Southeast Asia is expected to grow rapidly to become a major market for the company apart from ...

    http://www.scmp.com/article/434181/broad-intelligence-seeks-raise-78m
  4. Zhejiang three aim for 2.2b yuan

    Posted Jan 20th 2005, 12:00am by Eric Ng

    ... panel member Shen Ran, a director at Hangzhou Minsheng Pharmaceutical Group, said his company intended to appoint Citic Capital as the sponsor for a listing to raise between 600 million yuan and 700 million yuan late this year or early next year. Mr Shen said the company made more than 200 pharmaceutical products as well as exporting raw materials for drugs to the United States, ...

    http://www.scmp.com/article/486201/zhejiang-three-aim-22b-yuan
  5. Banks take action against drug firms

    Posted Sep 18th 2004, 12:00am by Louis Beckerling

    ... for the repayment of a loan of HK$30.2 million. A hearing has been set for October 20. DBS is one of a string of creditors claiming money from Shanxi Central and its owners. The pharmaceutical company ... Louis Beckerling Bankers have taken legal action to secure the assets of Far East Pharmaceutical Technology amid fears over the repayment of an US$80 million syndicated loan. ...

    http://www.scmp.com/article/470859/banks-take-action-against-drug-firms
  6. Goldman Sachs invests US$40m in drug firm

    Posted Jul 13th 2004, 12:00am by Mark O'Neill

    ... Mark O'Neill in Shanghai Investment bank Goldman Sachs has agreed to invest US$40 million in Shenzhen Neptunus Pharmaceutical, a privately owned chain of pharmacies, aiming to turn it into the biggest in China and list it abroad within five years. Shenzhen Neptunus Pharmaceutical posted turnover of 700 million yuan last year from its 520 nationwide outlets, including branches ...

    http://www.scmp.com/article/462938/goldman-sachs-invests-us40m-drug-firm
  7. President forms retail venture on mainland

    Posted Apr 10th 2004, 12:00am by Staff Reporter

    ... Winston Yau President Chain Store Corp, Taiwan's largest convenience store operator, is rolling out a new retail cosmetics and pharmacy joint venture on the mainland, Shenzhen President Cosmed Corp. The Taiwanese company and local partner Livzon Pharmaceutical Group will set up the first Cosmed stores in Shenzhen and Guangzhou. 'We are after fast-growing markets ...

    http://www.scmp.com/article/451600/president-forms-retail-venture-mainland
  8. US fund buys into China drug firm

    Posted Dec 21st 2004, 12:00am by Eric Ng

    ... status. The Hayao Group posted sales of nearly 7.3 billion yuan last year. Hayao is not the first mainland drug company to tap foreign funds to help fund a restructuring. Huabei Pharmaceutical ... Pharmaceutical Group (Holdings), one of China's largest drugmakers. The investment is a rare marriage of convenience between the world's second-largest buy-out fund and a major state-owned ...

    http://www.scmp.com/article/482944/us-fund-buys-china-drug-firm
  9. IPO appetite growing again

    Posted Nov 27th 2004, 12:00am by Staff Reporter

    ... to subscribe to the public offer.' The public offer will start next Tuesday and close on Friday. The retail tranche of China Shineway Pharmaceutical, a maker of modern Chinese medicines seeking up ...

    http://www.scmp.com/article/479815/ipo-appetite-growing-again
  10. LifeTec revamp produces results

    Posted May 05th 2004, 12:00am by Staff Reporter

    ... for now. It is used to treat hepatitis B and C. LifeTec acquired a mainland drug distribution company and disposed of its 65.7 per cent interest in Weihai Sinogen Pharmaceutical Co last year, ... in its pipeline, according to chairman Jay Chun. The company, listed on the main board since 1997, has also produced something novel for a Hong Kong biotechnology firm: a full-year profit, thanks ...

    http://www.scmp.com/article/454569/lifetec-revamp-produces-results

Pages

Login

SCMP.com Account

or